Manint Usawachintachit1,2, Dylan S Isaacson1, Kazumi Taguchi1,3, David T Tzou1, Ryan S Hsi1,4, Benjamin A Sherer1, Marshall L Stoller1, Thomas Chi1. 1. 1 Department of Urology, University of California , San Francisco, San Francisco, California. 2. 2 Division of Urology, Faculty of Medicine, Chulalongkorn University , King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand . 3. 3 Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences , Nagoya, Japan . 4. 4 Department of Urologic Surgery, Vanderbilt University School of Medicine , Nashville, Tennessee.
Abstract
OBJECTIVE: LithoVue™ is a novel, single-use, digital flexible ureteroscope that was released to the US market in January 2016. There are scant data regarding its performance in humans. Procedural outcomes comparing LithoVue with reusable ureteroscopes are presented in patients undergoing ureteroscopy for upper urinary tract pathology. PATIENTS AND METHODS: Clinical outcomes between two groups of patients undergoing flexible ureteroscopy for upper urinary tract pathology were analyzed. The first group underwent surgery utilizing LithoVue, and the second group used reusable fiber-optic flexible ureteroscopes. Differences in procedural outcomes, operative times, and time spent in hospital were analyzed using two-tailed t-tests and chi-squared and Fisher's exact tests. RESULTS: One hundred fifteen cases utilizing LithoVue and 65 cases utilizing reusable ureteroscopes were included in this study. Demographics, surgical indications, stone size, location, total stone burden, composition, procedural outcomes, and complications were comparable between groups. For all cases, LithoVue procedures lasted 54.1 ± 25.7 minutes compared with 64.5 ± 37.0 minutes for reusable scope procedures (p < 0.05) and for stone removal cases, 57.3 ± 25.1 vs 70.3 ± 36.9 minutes, respectively (p < 0.05). Scope failure occurred in 4.4% of LithoVue cases and 7.7% of reusable cases (p = 0.27). CONCLUSIONS: LithoVue represents a feasible alternative to reusable ureteroscopes with a low rate of scope failure comparable with reusable ureteroscopes. Its use shortens procedure duration, a finding that warrants further investigation.
OBJECTIVE:LithoVue™ is a novel, single-use, digital flexible ureteroscope that was released to the US market in January 2016. There are scant data regarding its performance in humans. Procedural outcomes comparing LithoVue with reusable ureteroscopes are presented in patients undergoing ureteroscopy for upper urinary tract pathology. PATIENTS AND METHODS: Clinical outcomes between two groups of patients undergoing flexible ureteroscopy for upper urinary tract pathology were analyzed. The first group underwent surgery utilizing LithoVue, and the second group used reusable fiber-optic flexible ureteroscopes. Differences in procedural outcomes, operative times, and time spent in hospital were analyzed using two-tailed t-tests and chi-squared and Fisher's exact tests. RESULTS: One hundred fifteen cases utilizing LithoVue and 65 cases utilizing reusable ureteroscopes were included in this study. Demographics, surgical indications, stone size, location, total stone burden, composition, procedural outcomes, and complications were comparable between groups. For all cases, LithoVue procedures lasted 54.1 ± 25.7 minutes compared with 64.5 ± 37.0 minutes for reusable scope procedures (p < 0.05) and for stone removal cases, 57.3 ± 25.1 vs 70.3 ± 36.9 minutes, respectively (p < 0.05). Scope failure occurred in 4.4% of LithoVue cases and 7.7% of reusable cases (p = 0.27). CONCLUSIONS:LithoVue represents a feasible alternative to reusable ureteroscopes with a low rate of scope failure comparable with reusable ureteroscopes. Its use shortens procedure duration, a finding that warrants further investigation.
Authors: Helena C Chang; David T Tzou; Manint Usawachintachit; Brian D Duty; Ryan S Hsi; Jonathan D Harper; Mathew D Sorensen; Marshall L Stoller; Roger L Sur; Thomas Chi Journal: J Endourol Date: 2016-11-01 Impact factor: 2.942
Authors: Steeve Doizi; Guido Kamphuis; Guido Giusti; Kim Hovgaard Andreassen; Thomas Knoll; Palle Jörn Osther; Cesare Scoffone; Daniel Pérez-Fentes; Silvia Proietti; Oliver Wiseman; Jean de la Rosette; Olivier Traxer Journal: World J Urol Date: 2016-09-26 Impact factor: 4.226
Authors: Jean de la Rosette; John Denstedt; Petrisor Geavlete; Francis Keeley; Tadashi Matsuda; Margaret Pearle; Glenn Preminger; Olivier Traxer Journal: J Endourol Date: 2013-12-17 Impact factor: 2.942
Authors: Christian Türk; Aleš Petřík; Kemal Sarica; Christian Seitz; Andreas Skolarikos; Michael Straub; Thomas Knoll Journal: Eur Urol Date: 2015-09-04 Impact factor: 20.096
Authors: Salvatore Butticè; Tarik Emre Sener; Christopher Netsch; Esteban Emiliani; Rosa Pappalardo; Carlo Magno Journal: Cent European J Urol Date: 2016-08-26
Authors: N F Davis; M R Quinlan; C Browne; N R Bhatt; R P Manecksha; F T D'Arcy; N Lawrentschuk; D M Bolton Journal: World J Urol Date: 2017-11-24 Impact factor: 4.226
Authors: Dylan Isaacson; Tessnim Ahmad; Ian Metzler; David T Tzou; Kazumi Taguchi; Manint Usawachintachit; Samuel Zetumer; Benjamin Sherer; Marshall Stoller; Thomas Chi Journal: J Endourol Date: 2017-09-20 Impact factor: 2.942
Authors: Laurian B Dragos; Bhaskar K Somani; Etienne X Keller; Vincent M J De Coninck; Maria Rodriguez-Monsalve Herrero; Guido M Kamphuis; Ewa Bres-Niewada; Emre T Sener; Steeve Doizi; Oliver J Wiseman; Olivier Traxer Journal: Transl Androl Urol Date: 2019-09